FDA approves GSK's bepirovirsen for chronic hepatitis B after a 19% functional cure rate, raising oligonucleotide scale-up ...
Ravi Kiran Kaja, PhD, USP, explains what harmonization of extractables and leachables standards looks like in practice. Ahead ...
OpenAI acquired Orchestra Bio to pair AI agents that track drug development timelines with its Rosalind life sciences tools, ...
The scope covers prescription drugs and drug-led, drug-device combination products where the Center for Drug Evaluation and ...
Germany is the European Union’s (EU) largest pharmaceutical market by revenue and has the highest medical biotechnology ...
Boyang Wang of Immortal Dragons explains how FDA's Expedited IND Pilot and QRIs could compress sequential first-in-human ...
This article examines how modern automation platforms create the digital foundation required for Pharma 4.0 by integrating ...
Medication nonadherence remains one of the widest gaps between how a drug performs in clinical trials and how it performs in ...
AstraZeneca and insitro announced on Oct. 15, 2026, a strategic drug discovery collaboration and licensing agreement that ...
The FDA’s Rare Disease Framework Initiative brings risk-based CMC review and pre-approval inspections into scope for sponsors ...
PharmTech covered one of the industry’s biggest events this week, as CPHI Milan was in full force with experts arguing that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results